Skip to main content

Table 2 Perioperative course of patients with CRLMs in the three age groups

From: Multidisciplinary treatment for colorectal liver metastases in elderly patients

Variable

≤ 64 years

65-74 years

≥ 75 years

p value

(n = 265)

(n = 151)

(n = 46)

Major hepatectomy, n (%)

53 (20.0)

36 (23.8)

9 (19.6)

0.628

 Operation time, min

305.0 (60-953)

275.0 (95-695)

263.0 (115-810)

0.194

 Blood loss, ml

390 (20-2640)

300 (10-6530)

265 (5-1910)

0.023

Surgical margin: positive, n (%)

15 (5.7)

8 (5.3)

2 (4.3)

0.934

 Preoperative chemotherapy, n (%)

107 (40.4)

47 (31.1)

12 (26.1)

0.057

 Adjuvant chemotherapy, n (%)

144 (54.3)

65 (43.5)

9 (19.6)

< 0.001

Complication

    

 Major complications, n (%)

17 (6.4)

9 (6.0)

3 (6.5)

0.981

 Biliary leakage, n (%)

9 (3.4)

6 (4.0)

2 (4.4)

0.926

 Intraabdominal hemorrhage, n (%)

3 (1.1)

2 (1.3)

1 (2.1)

0.847

 Surgical site infection, n (%)

24 (9.1)

14 (9.3)

3 (6.5)

0.837

 Postoperative hospital stay, days

14 (5-160)

15 (8-372)

15 (8-45)

0.338

 Mortality, n

0

0

0

 
  1. Continuous data expressed as median (range)
  2. CRLMs colorectal cancer liver metastases.